Nucleoside-Mediated Mitigation of 5-Fluorouracil-Induced Toxicity in Synchronized Murine Erythroleukemic Cells

• Published in: Toxicology and applied pharmacology Vol. 146; no. 1; pp. 29 - 39
• Main Authors: Elstein, Kenneth H., Mole, M.Leonard, Setzer, R.Woodrow, Zucker, Robert M., Kavlock, Robert J., Rogers, John M., Lau, Christopher
• Format: Journal Article
• Language: English
• Published: San Diego, CA Elsevier Inc 01.09.1997; Elsevier
• Subjects: Animals; Antimetabolites, Antineoplastic - toxicity; Biological and medical sciences; Cell Cycle - drug effects; Deoxycytidine - pharmacology; Deoxyguanine Nucleotides - metabolism; Drug toxicity and drugs side effects treatment; Embryo, Mammalian - drug effects; Embryo, Mammalian - metabolism; Female; Flow Cytometry; Fluorouracil - toxicity; Leukemia, Erythroblastic, Acute - pathology; Medical sciences; Mice; Miscellaneous (drug allergy, mutagens, teratogens...); Pharmacology. Drug treatments; Pregnancy; Rats; Rats, Sprague-Dawley; Thymidine - pharmacology; Thymine Nucleotides - metabolism; Enzyme; Toxicity; Transferases; Fluoropyrimidine derivatives; Rodentia; DNA synthesis; Thymidylate synthase; In vitro; Vertebrata; Mammalia; Methyltransferases; Mouse; Animal; Cell cycle; Nucleoside; Teratogen; Mechanism of action; Tumor cell; Fluorouracil
• ISSN: 0041-008X; 1096-0333
• DOI: 10.1006/taap.1997.8208

5-Fluorouracil (5-FU) is a chemotherapeutic agent known to retard embryonic growth and induce cleft palate and limb deformities. The predominant mechanism underlying its toxic action is thought to be inhibition of thymidylate synthetase (TS), and hence thymidine triphosphate (dTTP) synthesis, resulting in alteration of the balance of deoxynucleotide (dNTP) pools and disruption of DNA synthesis. Indeed, previously we demonstrated retarded cell-cycle progression concurrent with a 60% decrease in TS activity in rat whole embryos following maternal exposure to 40 mg/kg 5-FU on Gestational Day 14 and in the murine erythroleukemic cell (MELC) suspension culture following exposure to 5–25 μm5-FU for 2 hr. In the study described herein, we used high-performance liquid chromatography (HPLC) to demonstrate in both of these model systems that 5-FU exposure results in similar patterns of dNTP perturbations: a prolonged decrease in dTTP and dGTP levels and an increase in dCTP and dATP. In addition, we used centrifugal elutriation to synchronize MELC in the phases of the cell cycle (G0/G1and early S) most sensitive to 5-FU to investigate the ability of nucleoside supplementation to mitigate 5-FU-induced toxicity. Our data indicate that following a 2-hr exposure to 5–25 μm5-FU, supplementation with 1–10 μmthymidine (TdR) for 24 hr partially reverses 5-FU-induced toxicity as evidenced by increased cellular proliferation and cell-cycle progression and amelioration of 5-FU-induced perturbations of protein synthesis and cellular membrane permeability compared to unsupplemented 5-FU-exposed cells. However, TdR concentrations ≥100 μminhibited growth or were cytotoxic. In comparison, supplementation with 10 μm–10 mmof deoxycytidine (CdR) was not toxic, but effected a dose-dependent recovery from 5-FU-induced toxicity. At 1–100 μm, neither deoxyadenosine nor deoxyguanosine supplementation reduced 5-FU-induced toxicity; at higher concentrations, both purine nucleotides inhibited cell growth. Although these results support the hypothesis that 5-FU disrupts the MELC cell cycle by depleting dTTP (a perturbation that is reversible by TdR supplementation), they also indicate that CdR supplementation offers an additional recovery pathway.